iCAD, Inc. (NASDAQ:ICAD) Shares Acquired by waypoint wealth counsel

waypoint wealth counsel boosted its holdings in iCAD, Inc. (NASDAQ:ICAD) by 44.0% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 14,400 shares of the technology company’s stock after buying an additional 4,400 shares during the period. waypoint wealth counsel’s holdings in iCAD were worth $26,000 at the end of the most recent reporting period.

Separately, Essex LLC purchased a new stake in shares of iCAD in the third quarter worth about $216,000. 24.61% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Separately, StockNews.com upgraded shares of iCAD from a “sell” rating to a “hold” rating in a research note on Thursday, November 21st.

iCAD Stock Up 2.5 %

iCAD stock opened at $2.42 on Monday. iCAD, Inc. has a 12-month low of $1.18 and a 12-month high of $2.65. The firm’s fifty day moving average price is $1.86 and its 200 day moving average price is $1.68.

iCAD Profile

iCAD, Inc engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis.